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Restoration of epithelial barrier function prevents chronic inflammation upon 
facing intestinal microflora when tissue damages have occurred. Dysfunctional 
tissue regeneration is commonly considered to be a cause of inflammatory bowel 
diseases (IBDs). Macrophage is a fundamental component of wound healing, 
however, the key elements for generating a tissue regenerating phenotype of 
intestinal macrophage remain elusive. Here I found that E prostanoid receptor 4 
(EP4) expression in macrophages is critically required for tissue regeneration in a 
damaged intestinal milieu. Csf1r-Cre/Esr1EP4fl/fl mice did not go through 
appropriate tissue regeneration with shortened colon length and prolonged disease 
activity index after recovery phase of dextran sodium sulfate induced colitis model. 
EP4+ macrophages are marked by high CD206 expression and high intracellular 
cAMP level at the resolution phase of colitis, implicating a functional significance 
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of EP4 in the formation of wound healing macrophages. RNA sequencing from 
sorted macrophages identified a Cxcl1 secreted from EP4+ intestinal macrophages 
as a driving factor for the epithelial proliferation from regenerating crypts via the 
PGE2/EP4/MAPK signaling axis. These studies thus define an important role of 
EP4 expression on intestinal macrophages to revive damaged epithelium. 
 
Keywords: Inflammatory Bowel Diseases, E prostanoid receptor 4, macrophage, 
intestinal regeneration, C-X-C motif chemokine 1. 
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Intestinal mucosal healing is the final clinical criteria for the determination of complete 
remission in IBD patients (1, 2). Anatomical uniqueness of intestine renders mucosal 
healing as one of the most important requisites for the therapeutic effectiveness because 
of its role in preventing a direct contact between our body’s immune system with the 
outside microbiota and food antigens (3, 4). During homeostasis, the epithelial barrier is 
maintained by highly active stem cells residing at the base of the crypts that provide 
continuous and perpetual cell renewal, with the majority of the differentiated cells being 
replaced every 3-5 days (5). However, in response to injury, additional mechanisms are 
rapidly implemented to restore the epithelial barrier. Delay or failure to do so can facilitate 
exposure to luminal antigens and potentially direct invasion of luminal microorganisms 
into the host, resulting in a heightened pro-inflammatory response, worsened tissue 
damage, and systemic infection. However, current standard therapies do not directly 
augment the mucosal healing, by contrast, they sometimes inhibit the natural process of 
mucosal healing by lowering several mediators inducing healing process at later 
sequences (2). 
 
Among the many anti-inflammatory agents, non-steroidal anti-inflammatory drugs 
(NSAIDs) are contraindicated in gastrointestinal disorders (6). The first reason to be 
widely recognized why the NSAIDs aggravate intestinal lesion and abrogate wound 
healing is that NSAIDs have a mode of mechanism that block the action of 
cyclooxygenase-1 or –2 (COX-1/2) which produce prostaglandins (PGs) having many 
direct protective effects in maintaining enterocytes (ECs) homeostasis (7). Likewise, 
glucocorticoids, which reduce PGs synthesis by suppressing phopholipase A2, COX-2 
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and mPGES2 expression, adversely affect the wound healing of intestinal epithelium. 
Meanwhile, given that the mucosal healing process as a complex interaction between 
enterocytes and stromal cells, there are not sufficient works whether PGs augment the 
mucosal healing via the action on the stromal cells playing in the intestinal tissue repair 
other than enterocytes. Delineating the cellular and molecular mechanisms that modulate 
healing process via PGs provides an opportunity to identify detailed components that 
normally regulate the proliferative activities of epithelial progenitors. This hopefully will 
give a new approach to enhance therapeutic responses in IBD patients (Figure 1). 
 
Figure 1. Inflammatory bowel disease pathogenesis and therapeutic approaches 
Left panel: IBD pathogenesis (Injured epithelium, invading bacteria, Accumulation of 
immature macrophages, Increased Th1/Th7 responses) (1). Right panel: concepts of 
studies for IBD treatment. Previous studies focused on suppression of inflammation or 
stimulation of intestinal stem cell for IBD treatment (2). Advantages of new approaches 
(cell-cell network) have advantages that can regulate inflammation and at the same time 
stimulate epithelial proliferation (3). Cross-talk between macrophages and intestinal 
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stem cells in the intestine has implications for advances in regenerative medicine, and 
improved therapeutic strategies for inflammatory bowel disease. 
 
Among the downstream lipid mediators of COXs, prostaglandin E2 (PGE2) has been 
known to have association with muscle and intestinal regeneration (8, 9). Majority of its 
effects were investigated on the parenchymal cells itself, in that PGE2 expands skeletal 
muscle-specific stem cells via the E prostanoid receptor 4 (EP4) after injury by triggering 
a cyclic AMP (cAMP)/phopho CREB pathway that activates the proliferation inducing 
transcription factor, Nurr1(8). In intestine, PGE2 induces differentiation of epithelial stem 
cells to wound-associated epithelial cells through EP4 (9). In case of skin, the effect of 
PGE2 was recently reported in relation with M2 macrophage polarization and enhancing 
wound healing (10). However, its specific mode of action remains unclear and the exact 
actions of PGE2 on the wound healing macrophages specifically in intestine still remain 
unresolved. In my previous study, endogenous PGE2 contributed to the M2 
characterization of resident macrophages, and promoted the pro-tumoral functions of 
tumor associated macrophages (TAMs) (11). Getting an idea from these and a study from 
Megan M et al. (12), showing the transcriptional similarities of wound healing 
macrophages with the TAMs, I hypothesized that PGE2 is required for the wound healing 
function of intestinal macrophages. By using myeloid cell specific PGE2 receptor 
knockout mice, I revealed in this study that E prostanoid receptor 4 (EP4) expressing 
macrophages was a critical component of colonic epithelial stem cell niche. They led the 
epithelial regeneration via production of Cxcl1 during colitis. EP4 was a potent, non-
redundant receptor for the function of CD206+ intestinal wound healing macrophages and 
was specifically required for the Cxcl1 synthesis during colitis, a previously unidentified 
molecule for a stem cell niche stimulation. 
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MATERIALS AND METHODS 
Mice  
Animal experiments were conducted in accordance to the Institute for Experimental 
Animals College of Medicine and cared for according to the Guide for the Care and Use 
of Laboratory Animals prepared by the Institutional Animal Care and Use Committee of 
Seoul National University (accession number SNU-171016-1-2). Male and female (10-
12 weeks old) Csf1r-Cre (Tg(Csf1r-Mer-iCre-Mer)1Jwp strain) mice, Ai14 
(Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) mice, EP2 KO (Ptger2tm1Brey/J) mice were 
purchased from Jackson Laboratory and Ptger4 floxed mice were kindly provided by Dr. 
Matthew Breyer (Eli Lilly and Company). Csf1r-cre;Ptger4fl/fl (Ptger4MφKO) mice were 
generated by crossing Csf1r-Cre mice with Ptger4 floxed mice. Csf1r-Cre;Ai14 mice 
were generated by crossing Csf1r-Cre mice with Ai14 mice. For Csf1r specific EP4 
ablation, tamoxifen (T5648; Sigma-Aldrich, St. Louis, MO, USA) is added to the diet as 
a tamoxifen-sucrose mixture. Csf1r specific EP4 knockout was achieved by feeding diet 
with 400 mg/kg tamoxifen with 5% sucrose to mice. Csf1r-Cre-Ai14 mice were injected 
with approximately 200 μl tamoxifen solution (200 mg/kg) once a day over 5 days. As 
control animals, co-housed and Cre-negative littermate mice were used in all experiments. 
All mice were housed in cages with a constant-flow air exchange supporting specific 
pathogen free condition. They were fed standard lab chow and they had access to water 
ad libitum.  
 
Analysis of human microarray and RNA-seq data 
All transcriptome data were retrieved from Gene Expression Omnibus (GEO) database 
(13). For microarray data, the series matrix files were downloaded and expression values 
were z-normalized for each sample. In the case of RNA-seq data, raw sequence read files 
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were downloaded and filtered by using fastp with default parameters (14). The remaining 
reads were then aligned to reference human transcriptome using kallisto to quantify 
expression levels (15).The reference human transcriptome annotation data (GRCh38.p13) 
were retrieved from GENCODE release 32 (16). Transcript-level expression values were 
merged into gene-level values by adding TPM values of all isoforms for each gene. Then, 
we used [Wilcoxon rank-sum test] to compare expression levels of PTGER4 between 
patients with ulcerative colitis and healthy controls. 
 
DSS-induced colitis model  
For induction of colitis, mice received one cycle (five days) of 2.5% DSS (MP 
Biomedicals, Santa Ana, CA, USA) in their drinking water. Animal weights were 
measured daily. Disease activity index (DAI) is the combined score of animal weight loss, 
stool  consistency and bleeding present in the stool as described in Table 1. Mice were 
sacrificed at the indicated time points for futhur study.   
 
Epithelial and lamina propria cell isolation 
Colons were removed and washed in PBS. After removing all excess fat and faeces, the 
intestines were opened longitudinally, washed in Hank's balanced salt solution 
(Invitrogen, Carlsbad, CA, USA) containing 1% FBS, and cut into 0.5 cm sections. Tissue 
was incubated at 37°C shaking twice for 15min in HBSS (1mM EDTA,1% FBS) to 
remove the epithelial layer. Supernatant was collected and epithelial cells were obtained 
after centrifugation (5 min, 1,300 r.p.m.). Intestinal pieces were cut and incubated with 
pre-warmed 1.25 mg/ml collagenase D (Roche, IN 46256, USA), 0.85 mg/ml collagenase 
V (Sigma-Aldrich, St. Louis, MO, USA), 1 mg dispase (Invitrogen, Carlsbad, CA, USA), 
and 30 U/ml DNase (Roche, IN 46256, USA) in Minimum Essential Medium (MEM) α 
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Medium (Invitrogen, Carlsbad, CA, USA) containing 2 mM l-glutamine, 1% 
penicillin/streptomycin, 2-Mercaptoethanol, and 10% FBS for 30–45 min in a shaking 
incubator at 37 °C. The resulting cell suspension was passed through a 70 μm cell strainer 
(BD Falcon) and lamina propria cells were collected after centrifugation (10 min,1,500 
r.p.m). 
 
Generation of bone marrow derived macrophages 
Bone marrow cells were obtained from Csf1r-Cre/Esr1 EP4fl/fl mice and differentiated 
into bone marrow derived macrophages (MPs) for 7 days in RPMI 1640 media containing 
10% FBS, 1% penicillin/streptomycin, and 2 mM of L-glutamine (ThermoFisher 
Scientific, Waltham, MA 02451, USA), and supplemented with fresh recombinant murine 
M-CSF (50 ng/ml; Miltenyi Biotec, Bergisch Gladbach, Germany) and 4-
Hydroxytamoxifen (6 μM; Sigma-Aldrich, St. Louis, MO, USA) every three days. 
 
Adoptive transfer of bone marrow derived cells. 
For adoptive transfer of dendritic cells (DCs), bone marrow cells were cultured in 
complete medium with recombinant GM-CSF (20 ng/ml; Miltenyi Biotec, Bergisch 
Gladbach, Germany) and IL-4 (5 ng/ml; Peprotech, Rocky Hill, NJ , USA). All cells were 
cultured at 37°C in a humidified incubator containing 5% CO2. MPs were routinely > 95% 
F4/80+/CD11b+ cells and DCs were routinely > 40% CD11c+ CD11bint MHChi cells. Cells 
were washed with PBS and transferred to Csf1r-cre;Ptger4fl/fl mice by intraperitoneal (IP) 
injection at 2 × 106 cells per mouse. 
 
Quantitative Real-time PCR  
For quantitative real-time PCR analysis, total RNA was solubilized in TRIzol reagent 
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(Invitrogen, Carlsbad, CA, USA) and extracted according to the manufacturer’s 
instructions. cDNA was synthesized from 1 mg of total RNA using reverse transcription, 
and the amount of mRNA was determined using real-time PCR analysis with the SYBR 
Green qPCR Pre Mix (Enzynomics, Daejeon, Republic of Korea) on an ABI real-time 
PCR 7500 machine (Applied Biosystems, Foster City, CA, USA). Samples were 
normalized to TBP or 18S ribosomal RNA. The primer sequences are described in Table 
2. 
 
Western Blotting  
Total cell lysates were prepared by harvesting cells in sample buffer (Biosesang, 
Seongnam, GG, Republic of Korea) with protease inhibitor and phosphatase inhibitor 
(GenDepot), sonicated for 40 s and heated to 99°C for 5 min. Proteins were resolved on 
12% polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Merck 
Millipore, burlington, MA, USA). The following Abs were used: anti–EP4 (101775; 
Cayman, Ann Arbor, MI, USA) and anti-β-actin (sc-47778; Santa Cruz Biotechnology, 
Dallas, TX, USA). 
 
Flow cytometry  
Following incubation with purified anti-CD16/CD32 for 10 mints at 4°C, 1x106 cells 
were stained at 4°C in the dark using the antibodies listed in Table 3 and analyzed using 
an LSR II or FACS Aria I cytometer (BD Biosciences, San Jose, CA, USA) and FlowJo 
software (Treestar inc, Ashland, OG, USA). Intracellular staining was done after cell 
fixation and permeabilization (BD Biosciences, San Jose, CA, USA) followed by 






At autopsy, the length of the colon was measured and a section of colon was fixed with 
4% paraformaldehyde and evaluated microscopically for inflammation indices by H&E 
staining. Histological scores of DSS-treated Csf1r-EP4f-/- mice were assessed by three 
indices: severity of inflammation (0 to 3), crypt damage (0 to 5), and ulceration (0 to 3).  
 
Immunofluorescence staining 
Frozen mouse colon tissues were sectioned to a thickness of 5 μm and fixed with ice-cold 
acetone for 10min. The tissue sections were incubated for 1h with blocking buffer (5% 
FBS, 0.3% Triton X-100 in PBS) at room temperature. The following primary antibodies 
were used: anti-F4/80 (MCA497GA; Bio-Rad, Hercules, CA, USA), anti-EP4 (101775; 
Cayman, Ann Arbor, MI, USA), anti-ki-67 (12202; Cell signaling, Danvers, MA, USA), 
anti-EpCAM (118207; Biolegend, Way San Diego, CA, USA), anti-Cxcl1 (MAB453; 
R&D systems, Minneapolis, MN, USA), anti-CD206. The tissue sections were incubated 
with primary antibodies overnight at 4°C in a humidified chamber. On the next day, 
appropriate secondary antibodies were applied, and nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI, D8417; Invitrogen, Carlsbad, CA, USA) before 
mounting. Fluorescence signal was detected using a Leica TCS SP8 confocal microscope. 
 
Immunohistochemistry 
Tissues were fixed in 4% paraformaldehyde (Merck Millipore, burlington, MA, USA) in 
PBS for 1 day and sectioned at a thickness of 4.0 μm. Slides were deparaffinized, 
rehydrated, and antigen-retrieved in a citrate buffer (10 mM sodium citrate, 0.05% Tween 
20, pH 6.0) for further analysis. Primary antibodies were pre-diluted in blocking buffer 
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to 1:200 for ki-67 (12202; cell signaling) and were applied to tissue sections overnight at 
4°C in a humidified chamber. Biotinylated secondary antibodies were applied, followed 
by signal development with liquid DAB substrate (K3467; Dako). Sections were 
counterstained with hematoxylin (Merck Millipore, burlington, MA, USA). Imaging was 
performed using microscope (Eclipse Ci-L; NIKON) 
 
ELISA 
Colons were homogenized in Homogenization buffer (0.1M phosphate, pH 7.4, 
containing 1mM EDTA and 10 μM indomethacin) using TissueLyser (Qiagen, Valencia, 
CA, USA). IL-10, TNF-α, CXCL-1 in cell culture supernatants or colon lysate were 
measured using mouse Duoset ELISA kit (BD Biosciences, San Jose, CA, USA) 
according to the manufacturer’s protocol. PGE2 levels were measured using a PGE2 
ELISA Kit (Cayman, Ann Arbor, MI, USA) 
 
Intestinal macrophage isolation and RNA Sequencing  
To isolate intestinal macrophages from lamina propria cells, CD45+CD11b+Ly6G-Ly6C-
MHCII+CD64+ intestinal macrophages were sorted using FACS AriaIII (BD Biosciences, 
San Jose, CA, USA) and prepared for further analysis. Sorting purity was assessed and 
confirmed to be up to 95-98%. Total RNA was extracted using TRIzol reagent (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s instructions. For control and test 
RNAs, the construction of the library was performed using the QuantSeq 3’ mRNA-Seq 
Library Prep Kit (Lexogen, Vienna, Austria) according to the manufacturer’s instructions. 
High-throughput sequencing was performed using single-end 75 sequencing on a 
NextSeq 500 (Illumina, San Diego, CA, USA). QuantSeq 3’ mRNA-Seq reads were 
aligned using Bowtie2 (Langmead and Salzberg, 2012). Bowtie2 indices were either 
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generated from genome assembly sequence or representative transcript sequences for 
aligning to the genome and transcriptome. The alignment file was used for assembling 
transcripts, estimating their abundances, and detecting differential expression of genes. 
Differentially expressed genes were determined based on counts from unique and 
multiple alignments using coverage in Bedtools (Quinlan AR, 2010). The RT (Read Count) 
data were processed based on the global normalization method using the Genowiz™ 
version 4.0.5.6 (Ocimum Biosolutions, Hyderabad, India). Gene classification was based 
on searches done by DAVID (http://david.abcc.ncifcrf.gov/) and Medline databases 
(http://www.ncbi.nlm.nih.gov/). Enriched terms that passed P-value < 0.05 were reported. 
All sequencing data can be found at the Gene Expression Omnibus (GEO) database 
(GSE141093). 
 
Crypt isolation and in vitro organoids cultivation  
Intestinal crypts were dissociated from mouse small intestine using Cell Dissociation 
buffer (0.5mM EDTA in PBS). Crypts were subsequently used for establishing organoids 
by cultivation in Matrigel (BD Biosciences, San Jose, CA, USA) and Intesticult medium 
(Stemcell Technologies). Briefly, crypts were re-suspended in Intesticult medium at 104 
crypts/ml and mixed 1:1 with Matrigel. Next, 50 μl Matrigel plugs were plated in pre-
warmed 24-well plates and allowed to settle, before addition of 750 μl of prewarmed 
Intesticult medium and subsequently cultured at 37 °C in a 5% CO2 atmosphere. Next 
day, some wells were treated with either 5% culture supernatant of lamina propria cells 
isolated from WT and Csf1r-EP4-/-mouse or 10 ng/ml recombinant Cxcl1 (Peprotech, 
Rocky Hill, NJ, USA). Fresh medium was replaced 4d of cultivation. After 7 days, 
intestinal organoids were analyzed for the efficiency of budding crypts and were used for 
Immunofluorescence staining. For Immunofluorescence staining of crypt organoids, ice 
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cold cell dissociation buffer was added to the wells and the organoids gently pipetted to 
disrupt the Matrigel plug. The organoids were then allowed to settle by gravity, the 
supernatant discarded and then washed 3 more times in ice cold PBS. The dissociated 
crypts were then allowed to settle by gravity, re-suspended in PBS and fixed with 4% 
paraformaldehyde.  
 
Statistical analysis  
Mann–Whitney U-test was used to determine statistical significance between groups 
using the GraphPad Prism Software v.6 (GraphPad, La Jolla, CA, USA). P-value of less 
than 0.05 was considered statistically significant, represented by *P<0.05, **P<0.01, 






Expression of E prostanoid receptor 4 is related with resolution of colitis 
Although the genome-wide association studies have reported that the PTGER4 gene, 
which encodes the PGE2 receptor EP4, has a strong genetic association with both forms 
of IBD, the exact expression patterns of the PTGER4 in the colitis have not been clarified. 
To further investigate the expression of EP4 in human patients, I first analyzed 
transcriptome data of human IBD samples and found significant downregulation of 
mRNA expression levels of the PTGER4 in samples from both Crohn’s disease (CD) and 
ulcerative colitis (UC) patients relative to those in healthy controls (Figure 2A-E). 
Furthermore, expression levels of the PTGER4 in samples of UC patients under remission 
state were increased (Figure 2F-G). These results indicate that expression of the PTGER4 
is largely related with remission of IBD patients. These findings raise the question 
concerning which cell types highly express EP4 in colon tissues. In fact, EP4 is required 
for epithelial cell survival and is one of the most abundant and potent EP receptors 
expressed in Th17 cells, I found that macrophages are the cells that highly expressed EP4 
in the colon. The expression of the EP4 was observed throughout the colon with 
enrichment on stromal cells in lamina propria (Figure 3A). Especially, EP4 was 
predominantly co-localized in the F4/80+ macrophages in the colonic lamina propria 
(Figure 3B). To further investigate the expression of EP4, EP4 levels were analyzed using 
fluorescence-activated cell sorting (FACS) in lamina propria of mouse normal colon 
tissue. I found that the expression of EP4 was increased during differentiation from 
monocytes to mature macrophages (Figure 3D). Also, macrophages were highly 
expressing EP4 in immune cells in lamina propria (Figure 3C-D). Taken together, the 
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above results indicate that macrophages which are highly expressing EP4 in lamina 
propria of colon tissue may contribute to the resolution of intestinal inflammation. 
 
Endogenous prostaglandin E2 potentiates anti-inflammatory phenotype of macrophage 
through CREB-C/EBP-β cascade 
Before I examine the role of PGE2-EP4 signaling of macrophage in the resolution of 
colitis, I tested the initial hypothesis that PGE2 is required for the wound healing function 
of macrophages. Through my previous study, I found that differentiating bone marrow 
derived macrophages (BMDMs) under the effect of M-CSF produce PGE2 endogenously, 
resulting in anti-inflammatory gene expression upon differentiation induced by 
macrophage colony stimulating factor (11). COX inhibition by indomethacin reduced 
endogenous PGE2 production of macrophages and subsequently reduced interleukin-10 
(Il10), arginase (Arg1) and macrophage mannose receptor 1 (Mrc1) gene expressions (11). 
Consistent with my previous study, PGE2 increased Il10, Arg1, and Mrc1 gene 
expressions in macrophages (Figure 4A-C). Furthermore, my study identified that 
signaling by EP2 and EP4 is triggered by PGE2 binding, and then adenylate cyclase is 
activated, leading to an increase in intracellular cAMP levels, which in turn activates 
Protein Kinase A (PKA). Activated PKA then causes phosphorylation of cAMP response 
element-binding protein (CREB). This leads to the transcription of CCAAT-enhancer-
binding proteins beta (C/EBP-β) which promotes Il10, Arg1, and Mrc1 gene expression 
(Figure 4D) (11). Collectively, endogenous PGE2 promotes anti-inflammatory phenotype 
macrophage differentiation through the CREB/CEBP-β cascade.  
 
Generation and characterization of Csf1r-cre;Ptger4fl/fl mice  
To elucidate the role of EP4 of macrophages in resolution of colitis, I made myeloid cell 
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specific EP4 knockout mice. Mice carrying a floxed allele of Ptger4 were crossed to 
Csf1r-cre mice to generate Csf1r-cre;Ptger4fl/fl mice that will have a deletion of Ptger4 
restricted to myeloid cells (Figure 5A). Analysis of BMDMs-derived DNA from the 
Ptger4fl/fl mice with or without cre showed efficient ablation of the 340 bp floxed allele in 
the presence of Csf1r-cre with 4-hydroxytamoxifen (4-oht) treatment (Figure 5B). 
Feeding tamoxifen (Tm) diet (250mg/kg) to these mice induced Csf1r specific Ptger4 
ablation as shown by genotyping on the Ptger4 floxed allele from sorted CD115+ myeloid 
cells, CD45-CD31+ endothelial cells and CD45-EpCAM+ epithelial cells in colon. The 
presence of Ptger4 floxed allele was detected in all the tissue samples except in the 
targeted myeloid cell (Figure 5C). In addition, RNA of exon2 of Ptger4 was almost 
deleted and EP4 protein level was significantly decreased in sorted CD45+CD11b+Ly6G-
Ly6C-MHCII+ macrophages from colon of Csf1r-cre;Ptger4fl/fl mice. (Figure 6A-B). But 
RNA of exon2 of Ptger4 in epithelial cells from Csf1r-cre;Ptger4fl/fl mice was not 
different with WT (Figure 6C). Both RNA and protein of the WT versus Csf1r-
cre;Ptger4fl/fl BMDMs indicated EP4 deletion (Figure 6D-E). The cAMP level was 
measured to EP4 signaling activity and this result showed that cAMP level of colonic 
macrophages from Csf1r-cre;Ptger4fl/fl mice was decreased than that of Ptger4fl/fl mice 
(Figure 6F). My previous study identified that mouse BMDMs express 4 types of PGE2 
receptors, EP1 to EP4 with similar expression levels (11). In accordance with this, I 
detected all types of EPs on the macrophages isolated from the lamina propria of mouse 
colon with no big difference of expression levels detected by flow cytometry (Figure 7A). 
Because both EP2 and EP4 induce intracellular cAMP accumulation which has relation 
with M2 genes induction including Arg1, Mrc1 and resistin-like molecule alpha (Retnla) 
(11), I examined which EP receptor is a potent receptor for cAMP signaling. The cAMP 
levels of WT and EP2 KO BMDMs was significantly increased by PGE2, however Csf1r-
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cre;Ptger4fl/fl BMDMs did not respond to PGE2 stimulation. From this result, EP4 was 
identified as the strongest receptor for PGE2 that induced downstream cAMP signaling in 
macrophages (Figure 7B). In addition, analysis of endogenous Csf1r expression by 
crossing Csf1r-cre and Ai14 mice confirmed that Csf1r was specifically expressed in the 
monocytes, macrophages and dendritic cells as previously reported (Figure 8). About 45% 
of neutrophils and 43% of dendritic cells had tdTomato signal. In contrast, about 93% 
macrophages had that signal. This result indicated that cre-recombination event could 
mainly occur in macrophages in our mice. 
 
Monocyte derived EP4+ macrophages are essential for the mucosal repair during 
intestinal inflammation 
Before exploring the role of macrophage EP4 signaling in mucosal immune responses, I 
first characterization dextran sodium sulfate (DSS) induced colitis model in normal B6 
mice (Figure 9A). The body weight was decreased gradually until 7-8 days (inflammatory 
phase) and increased again until 20-25 days (resolution phase) (Figure 9B). Additionally, 
mice exhibited a significant increase in disease activity index (DAI) (Figure 9C), 
shortened colon length (Figure 9D) and increased histology score (Figure 9E) in the 
inflammatory phase. IBD is characterized by the infiltration and activation of various 
immune cells, leading to prolonged inflammation in the intestine. In order to identify the 
colonic cellular populations involved in acute and chronic DSS-induced colitis, Lamina 
propria (LP) leukocyte cells isolated from DSS-treated mice were examined. Similar to 
the body weight result (Figure 9B), I observed a significant increase in the number of 
CD45+ leukocytes in lamina propria until day 8 (Figure 10A). The number of Neutrophils 
peaked at day5 and was gradually decreased until day 28 (Figure 10B). An identical 
“waterfall” of Ly6Chi monocytes developing progressively into CD64+Ly6C-MHCII+ 
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mature macrophages in resting mouse intestine has also been proposed in a recent study 
(17). In that study, inflammation alters monocyte-macrophage differentiation, causes 
selective accumulation of both Ly6Chi monocytes and intermediates and decreased 
mature macrophage. In accordance with these reports, the number of monocytes (Figure 
10C) and intermediates (Figure 10D) was increased in the inflammatory phase. In contrast, 
the number of mature macrophages was decreased during the inflammatory phase and 
gradually increased until day 28 (Figure 10E). Collectively, these results show that my 
DSS colitis model is well characterized with previously reported features.  
To compare any gross difference of inflammatory phenotype between Ptger4fl/fl and 
Csf1r-cre;Ptger4fl/fl mice, I induced colitis by providing 2.5% DSS containing water for 
5 days. The recovery phase was followed for 12~33 days until Ptger4fl/fl mice re-gained 
original weights. Interesting result was found in the body weight curve, in that Ptger4fl/fl 
mice started to increase their weights from 7 days post DSS treatment (dpt) and almost 
recovered by 19 dpt, in contrast, Csf1r-cre;Ptger4fl/fl mice did not gain weight and stayed 
around 85% of starting point by 19 dpt (Figure 11A-B). This data directly connected to 
the DAI which scores the extent of bloody stool, consistency of stool in addition to the 
weight loss (Figure 11C). Ptger4fl/fl mice showed the highest DAI score by 5~7 dpt and 
revered to near homeostatic level, however, Csf1r-cre;Ptger4fl/fl mice showed delayed 
recovery of symptoms and stayed to the score of 4 by 19 dpt. Next, I sacrificed mice at 
each time point and observed colon length (Figure 11D). The length of the colon went 
similar with the weight curve in that Ptger4fl/fl mice had the most shortened colon by day 
5 and consistently lengthen colon till the day 28. Notably, Csf1r-cre;Ptger4fl/fl mice were 
evident to have uniformly short colons during the whole recovery phase.  
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Next, I determined whether the defect of normal recovery was come out from more severe 
extent of early inflammation in Csf1r-cre;Ptger4fl/fl mice. Distinct from whole cell EP4-/- 
mice which showed a significantly severe form of colitis from the initiation phase (), 
myeloid cell specific EP4 knockout induced a similar extent of inflammation as analyzed 
by myeloperoxidase (MPO) assay using the whole colon lysate (Figure 12A). Infiltrations 
of total leukocytes, neutrophils and monocytes were not significantly different, except the 
neutrophil counts by 5 dpt which were even lower in Csf1r-cre;Ptger4fl/fl compared to 
Ptger4fl/fl mice (Figure 12B-D). In accordance with this, histological scores were not 
different during the early inflammatory phase, whereas Csf1r-cre;Ptger4fl/fl mice showed 
significantly higher scores at later recovery phase due to the remnant of crypt loss and 
erosion, supporting the defect of the repair process in these mice (Figure 13). 
To examine the contribution of Csf1r positive macrophages to the regenerating intestine, 
I adoptively transferred Ptger4fl/fl bone marrow derived macrophages (MPs) or dendritic 
cells (DCs), which were the major two populations expressing Csf1r in the mouse 
intestine, to the Csf1r-cre;Ptger4fl/fl recipient mice in total three rounds during recovery 
phase (Figure 14A-B). As expected, Ptger4fl/fl MPs, not DCs injection, led to lengthen 
colons of recipient mice, which predicts that EP4 expressing macrophages are important 
in regeneration (Figure 14C). Collectively, these findings demonstrate that monocyte 
derived EP4 expressing macrophages are required for the proper mucosal repair during 
an ECs damage induced intestinal inflammation.        
 




To examine more closely on the defect of repair in Csf1r-cre;Ptger4fl/fl mice, I quantified 
crypt numbers per unit length in colons from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice by 
7 and 21 dpt. As a result, the number of crypts per 500 ㎛ was decreased by 7 dpt because 
of DSS mediated toxicity both in Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice (Figure 15A). 
At 21 dpt however, Ptger4fl/fl mice showed a marked increase in the number of crypts, 
whereas Csf1r-cre;Ptger4fl/fl mice had significantly lower crypts compared to Ptger4fl/fl, 
implicating the defect of the repair was relevant in a crypt regeneration. I next confirmed 
the Ki67+ epithelial cells which faithfully represent proliferating cells outward from crypt 
niche. Analysis by flow cytometry using isolated colonic epithelial cells (Figure 15B) and 
immunohistochemistry on fixed whole colons (Figure 15C) showed that proliferating 
epithelial cells in Csf1r-cre;Ptger4fl/fl mice was significantly lower compared to Ptger4fl/fl 
mice by 21 dpt in a resolution phase.  
To explore a sequential crypt response during colitis, I identified the transcripts of each 
cellular components in the whole epithelium (Figure 16A). Following damage by 7 dpt, I 
found that all transcript markers for the crypt including Lgr5 (crypt-base columnar cells, 
CBCs), Bmi1 (reserve stem cells, RSCs), Muc2 (goblet cells) and Reg4/Lyz1/Lyz2 (deep 
crypt epithelial cells), were steeply decreased, representing the crypt loss as previously 
reported. From 14 dpt during regeneration, these genes were transcriptionally increased 
in Ptger4fl/fl mice, whereas remained low in Csf1r-cre;Ptger4fl/fl mice at 21 dpt or 35 dpt 
(Figure 16B-C). Because the CBCs and RSCs are known to drive the turnover of the 
intestinal epithelium, these results demonstrate that EP4 expressing macrophages are 
required for the repair of the damaged intestine by probably supporting the regenerating 




Macrophage EP4 signaling promotes the wound healing function of colonic 
macrophages 
Previously concept on tissue repair poised macrophages as a critical arm of tissue 
regenerating machinery. In the intestine, CD206+ wound healing macrophages are known 
to participate in rebuilding damaged area (18, 19). Although IL-4 is the most powerful 
cytokine for inducing CD206+ alternatively activated macrophages (20), it is still not 
certain whether this scenario also fit in the intestine. Before exploring the involvement of 
EP4 expression with the function of wound healing macrophages, I first confirmed the 
involvement of IL-4 in the formation of CD206+ wound healing macrophages. I induced 
colitis in normal B6 mice by DSS treatment and followed the change in body weight with 
injection of IL-4 neutralizing antibody (nIL-4 Ab.) or corresponding isotype antibody 
three times a week throughout the whole recovery period (Figure 17A). Phosphorylation 
of Stat6 was decreased by nIL-4 (Figure 17B). Intriguingly, depletion of IL-4 did not 
affect the weight change during colitis, colon length by 25 dpt (Figure 17C), nor the 
development of CD206+ macrophages (Figure 17D). Another marker expression for 
wound healing macrophages including Arg1, Retnlα and IL-10 were not all different 
between isotype and nIL-4 Ab. received mice (Figure 17E), demonstrating that IL-4 was 
not an important factor for inducing intestinal repair.  
I next examined whether the EP4 expression contributed to the development of wound 
healing macrophages. As expected, by 39 dpt when the shortened colons were obviously 
observed in Csf1r-cre;Ptger4fl/fl mice (Figure 18A), decrease of CD206+ (Figure 18B) as 
well as Arg1+ and Retnlα+ macrophages (Figure 18C) were shown in Csf1r-cre;Ptger4fl/fl 
mice whereas the mature macrophage population itself was not different (Figure 18D). 
Notably, I detected a strong positive correlation of EP4 expression with the CD206 
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expression in intestinal macrophages by flow cytometry (Figure 18E), all supporting the 
notion that the EP4 expression of macrophages is required for the intestinal regeneration 
via the formation of wound healing macrophages.  
To define the mechanisms that underlie regeneration driven by EP4+ macrophages, I 
transcriptionally compared the Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mature macrophages 
isolated from colon by 39 dpt. Total 252 genes were differentially identified in RNA 
sequencing data and further analyzed for the enriched gene ontology biological processes 
(GOBPs) using the upregulated gene set (Category 1) in Ptger4fl/fl compared to Csf1r-
cre;Ptger4fl/fl macrophages (Figure 19A). As a result, wound healing signature including 
Mrc1, Retnlα, Igf1r, Anxa5, Cxcr4, Csrp1, Prkca and Arg1 was predominantly decreased 
in Csf1r-cre;Ptger4fl/fl macrophages (Figure 19B). Concomitantly, the regulation of 
multi-organ process, endothelial cell proliferation and tissue development were enriched 
in Ptger4fl/fl mice implicating the involvement of EP4+ macrophages in maintaining tissue 
homeostasis (Figure 19C-E). Several genes involved in immune response were also 
identified as decreased in Csf1r-cre;Ptger4fl/fl macrophages, including Cebpα, Cxcl1 and 
Prkca (Figure 19F). Collectively, these results demonstrated that EP4 expression governs 
the general feature of wound healing macrophages. Among the top significant transcripts, 
I next seek which molecule was directly involved in epithelial regeneration.  
 
Cxcl1 production from EP4+ macrophages is necessary for the intestinal epithelial 
regeneration 
To investigate whether soluble factors derived from EP4+ macrophages are relevant for 
the epithelial repair or not, I isolated lamina propria mononuclear cells (LPMC) of colon 
from WT mice and cultured overnight before collecting supernatants. Then the Csf1r-
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cre;Ptger4fl/fl mice were received 300 μl of LPMC sup intraperitoneally total six times 
from 20 to 30 dpt (Figure 20A). Treatment with LPMC sup from Ptger4fl/fl colon 
significantly lengthen colons of Csf1r-cre;Ptger4fl/fl mice, revealing the soluble factors 
were involved in epithelial regeneration (Figure 20B). For the possible candidates, I chose 
Cxcl1, one of the most significantly different genes between Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl macrophages and as a secretary molecule, for the major factor inducing 
epithelial regeneration given that its known function for stimulating cancer stem cell 
survival. As a result, Cxcl1 was exclusively detected in Ptger4fl/fl compared to Csf1r-
cre;Ptger4fl/fl LPMC sup (Figure 20C). Cxcl1 was predominantly co-localized in the 
F4/80+ macrophages in the colonic lamina propria of Ptger4fl/fl mice (Figure 21A-B) as 
determined by immunofluorescence staining, whereas Csf1r-cre;Ptger4fl/fl mice barely 
showed Cxcl1 expression in colon. These data indicate that macrophages are the major 
producers of Cxcl1 in the resolution phase of colitis and the majority of Cxcl1 is derived 
from EP4 signaling. 
To explore the direct effect of Cxcl1 in crypt regeneration, I isolated intestinal crypts from 
Ptger4fl/fl mice and cultured them in the matrigel with or without treatment of recombinant 
Cxc1. Surprisingly, 10 ng/ml of Cxcl1 obviously promoted epithelial regeneration as 
determined by crypt budding efficiency (Figure 22A-B) as well as the ratio of Ki67+ 
proliferating cells in the crypt (Figure 22C-E). Next, I treated LPMC culture medium 
(CM) to the regenerating crypts and confirmed higher budding efficiency in crypts 
cultured with CM from Ptger4fl/fl LPMC compared to Csf1r-cre;Ptger4fl/fl LPMC. 
Adding neutralizing antibodies for the Cxcl1(nCxcl1) in the CM of WT LPMC reverted 
the budding efficiency to the level of CM of Csf1r-cre;Ptger4fl/fl LPMC (Figure 23A-B). 
Similar with LPMC results, CM from Csf1r-cre;Ptger4fl/fl BMDMs decreased budding 
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efficiency in Crypts and nCxcl1 reverted effect of CM of WT BMDMs (Figure 23C-D). 
Collectively, these findings demonstrate that EP4+ macrophages induce intestinal 
regeneration via stimulation of epithelial proliferation from crypt in a Cxcl1-dependent 
manner.  
 
Cxcl1 is produced under the PGE2/EP4/MAPKs signaling pathway in the wound 
healing macrophages  
To define the exact molecular mechanisms of Cxcl1 production from macrophages, I first 
determined Cxcl1 gene transcripts in Ptger4fl/fl BMDMs with stimulation of 10 μM of 
PGE2. At 48 hours post PGE2 treatment, Cxcl1 mRNA was increased 30-fold (Figure 
24A). Notably, this was primarily mediated by EP4, because only Csf1r-cre;Ptger4fl/fl 
BMDMs did not increase Cxcl1 production upon PGE2 treatment whereas EP2
-/- and WT 
BMDMs significantly increased Cxcl1 (Figure 24B). I next analyzed PGE2 levels during 
colitis to examine a correlation between PGE2 and Cxcl1 levels. PGE2 itself was 
decreased in an inflammatory phase and increased above the homeostatic level during a 
recovery phase both in blood and colon lysates (Figure 24C-D), in line with previous 
reports. In line with this, Cxcl1 was decreased in blood and colon lysates derived from 
Csf1r-cre;Ptger4fl/fl mice at the recovery phase compared to Ptger4fl/fl (Figure 24E-F). 
Blocking endogenous COX activity by administrating indomethacin during colitis also 
showed shortened colon (Figure 24G) and reduced Cxcl1 levels in colon lysates (Figure 
24H), which suggests that the increased Cxcl1 during the recovery phase is correlated 
with the increased PGE2.   
Next, I investigated the underlying signaling pathway of PGE2 to the production of Cxcl1 
in macrophages. First, I confirmed whether PGE2 increases Cxcl1 through the 
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cAMP/PKA signaling pathway in macrophages, I treated adenylyl cyclase activator 
forskolin and PKA inhibitor. Forskolin did not increase Cxcl1 production and H89 
increased Cxcl1 rather than decreased (Figure 25A). This result indicated that 
cAMP/PKA dependent pathway is not involved in production of Cxc1and blocking of 
PKA pathway could activate another pathway involved in Cxcl1 production. Because 
PGE2 can increase expression of the Cxcl1 in colorectal cancer cells through the EGFR–
MAPK cascade (40), I investigated whether PGE2 up-regulates Cxcl1 through EGFR–
MAPK pathway. I found that inhibitors for each MAPK and inhibitor of EGFR abrogated 
PGE2-mediated Cxcl1 increases (Figure 25B-C). Taken together, these results showed 
that PGE2 increased Cxcl1 production by activation EGFR and MAPKs signaling in 
activated macrophages.  
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Table 1. Disease active index of DSS induced colitis  
Weight loss score Stool blood score Stool consistency score 
<1% 0 Absence 0 Formed and hard 0 
1~5% 1   Formed but soft 1 
5-10% 2 Presence 2 Loose stools 2 
10-20% 3   Mild diarrhea 3 




Table 2. Primer sequences for QRT-PCR 
Gene Primers 
Reg4 
Forward: CTGGAATCCCAGGACAAAGAGTG            
Reverse: CTGGAGGCCTCCTCAATGTTTGC 
Muc2 
Forward: CAGTTTATTCCTGTGTGCCCAAGG  
Reverse: GGCTTCAGAATAATGTACTGCTGC 
Bmi1 
Forward: AATTAGTTCCAGGGCTTTTCAA  
Reverse: CTTCATCTGCAACCTCTCCTCTAT  
Lgr5 
Forward: GGGAGCGTTCACGGGCCTTC  
Reverse: GGTTGGCATCTAGGCGCAGGG 
Lyz1 
Forward: GAGACCGAAGCACCGACTATG  
Reverse: CGGTTTTGACATTGTGTTCGC 
Lyz2 
Forward: ATGGAATGGCTGGCTACTATGG  
Reverse: ACCAGTATCGGCTATTGATCTGA  
Il-10 
Forward: GGACAACATACTGCTAACCGAC   
Reverse: CCTGGGGCATCACTTCTACC  
Cxcl1 













Table 3. List of used antibodies for Flow cytometry 
 
Antibodies Cat. No Supplier 
Anti-CD45 47-0451-82 e-bioscience 
Anti-CD11b 48-0112-80 e-bioscience 
Anti-Ly6G 551461 BD Pharmingen™ 
Anti-MHC Class II (I-A/I-E) 46-5321-80 e-bioscience 
Anti -Ly6C 128017 Biolegend 
Anti -CD64 558539 BD Pharmingen™ 
Anti FIZZ1/RETNL alpha NBP2-29355 Novus biologics 
Anti-Arginase 1 53-3697-82 e-bioscience 
Anti-CD206 141703 biolegend 
Anti-IL-10 11-7101-41 e-bioscience 
Anti-EpCaM 118207 biolegend 




anti- CD16/32 101301 biolegend 





Figure 2. Expression of mRNA of PTGER4 was decreased in the human IBD patients  
PTGER4 mRNA levels in the indicated IBD datasets. Box and whiskers graphs indicate 
the median and the 25th and 75th percentiles, with minimum and maximum values at the 
extremes of the whiskers. CD: crohn's disease, UC: ulcerative colitis. *P < 0.05, **P < 





Figure 3. EP4 receptor expression in mouse colon     
(A) Confocal images of colon sections of C57BL/6 mice stained for EP4 (green) and 
DAPI (blue). Scale bar = 100 μm. (B) Representative staining EP4 (green), F4/80 (Red) 
and DAPI (blue) on colon section. Arrows indicate double-positive cells. Scale bars = 100 
μm. (C) Flow cytometry analysis of colonic lamina propria immune cells. Quantitative 
graph for the intensities of EP4 are shown in right. (D) Expression of EP4 protein in 
monocytes (CD45+CD11b+Ly6G-Ly6C+MHCII-), intermediates (CD45+CD11b+Ly6G-
Ly6C+MHCII+) and macrophages (CD45+CD11b+Ly6G-Ly6C+MHCII+) from colon 




Figure 4. PGE2 potentiates anti-inflammatory phenotype of macrophage through 
CREB-C/EBP-β cascade 
Gene transcripts of Il0 (A), Arg1 (B) and Mrc1 (C) in bone marrow derived macrophages 
(BMDMs) determined using qPCR. BMDMs were treated with PGE2 (10 µM) for 8 hours 
(n=3. **P < 0.01). (D) Schematic figure shows the effect of endogenous PGE2 on 
macrophage differentiation. Signaling by EP2 and EP4 is triggered by PGE2 binding, and 
then adenylate cyclase is activated, leading to an increase in intracellular cyclic AMP 
(cAMP) levels, which in turn activates PKA. Activated PKA then causes phosphorylation 
of CREB. This leads to transcription of C/EBP-β which promotes Arg1, Il10, and Mrc1 
gene expression. Thus, PGE2 promotes anti-inflammatory macrophage differentiation 




Figure 5. Generation of macrophage specific EP4 KO mice 
(A) Generation of macrophage specific Csf1r-cre;Ptger4fl/fl mice. (B) PCR for the deleted 
allele of Ptger4 (floxed, 340bp) of DNA from BMDMs of Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl mice. To obtain an efficient deletion ex vivo, BMDMs were treated with 4-
hydroxytamoxifen (4-oht) on the day4 and day6 during differentiation. (C) PCR for the 
deleted allele of Ptger4 of DNA from sorted endothelial cell (CD45-CD31+), epithelial 
cells (CD45-EpCAM+) and myeloid cell (CD45+CD115+) of Ptger4fl/fl and Csf1r-





Figure 6. EP4 KO efficiencies of Csf1r-cre;Ptger4fl/fl mice 
(A-C) Mice with macrophage deletion of EP4 were generated by exposure to tamoxifen 
diet throughout experiment. (A) Real time quantitative PCR analysis to determine mRNA 
of exon2 of Ptger4 and (B) flow cytometry analysis to determine expression of EP4 
protein in sorted CD45+CD11b+Ly6G-Ly6C-MHCII+ macrophages of Ptger4fl/fl and 
Csf1r-cre;Ptger4fl/fl mice (***P<0.001). (C) Expression of mRNA of exon2 of Ptger4 in 
epithelial cells from colon of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice. (D-E) BMDMs 
were treated with 4-oht on the day4 and day6 during differentiation. (D) Real time 
quantitative PCR analysis to determine mRNA and (E) western blot analysis to determine 
protein levels of EP4 in isolated BMDMs from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice 
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(****P < 0.0001). (F) Expression of cyclic AMP protein in macrophages 
(CD45+CD11b+Ly6G-Ly6C+MHCII-) from colon lamina propria of Ptger4fl/fl and Csf1r-





Figure 7. EP receptor expression in mouse colon 
(A) EP 1-4 receptor protein content in CD45+CD11b+Ly6G-Ly6C-MHCII+ macrophages 
from mice colon determined using flow cytometry. Quantitative graph for the intensities 
of EP receptor are shown in right. (B) Production of cyclic AMP levels in BMDMs of WT 
(Ptger4fl/fl), EP2-/-and Csf1r-cre;Ptger4fl/fl mice after 15min of PGE2 treatment. BMDMs 
were treated with 4-oht on the day4 and day6 during differentiation (n=4. *P < 0.05, 






Figure 8. Distinct expression patterns of tdTomato in Csf1r+ cells of Csf1r-Ai14 mice 
Representative flow cytometry plot of lamina propria cells in and Csf1r-Ai14 (left) and 
Ai14 mice (right) mice. Mice were administered tamoxifen (Tm) or corn oil by i.p. 




Figure 9. Characterization of DSS induced colitis model 
(A) C57BL/6 mice were orally administered 2.5% DSS in drinking water for 5 days. (B) 
Percentage change in body weight. (n=7 per time point). (C) Disease activity index, a 
composite measure of weight loss, stool consistency and blood in stool (n=5-7 per time 
point, *p < 0.05, **p < 0.01, ***P < 0.001). (D) Left panel: representative images of mice 
colon at indicated time points. Right panel: Average of colon length with SEM at 
indicated time points. (E) Left panel: Representative images of hematoxylin and eosin 
staining of colon tissue from mice at indicated time points. Scale bars =100 μm. Right 
panel: Histological tissue damage and inflammation scoring at indicated time point (n=3 




Figure 10. The numbers of immune cells in the colon during DSS-induced colitis 
The number of CD45+ leukocytes (A), CD45+CD11b+Ly6G+ neutrophils (B), 
CD64+Ly6C+MHCII- monocyte (C), CD64+Ly6C+MHCII+ intermediates (D) and 






Figure 11. Csf1r- EP4-/- mice did not go through appropriate tissue regeneration 
(A) Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in 
drinking water for 5 days. Mice with macrophage deletion of EP4 were generated by 
exposure to tamoxifen diet throughout experiment. (B) Percentage change in body weight. 
(n=7 per time point, *P < 0.05, **P < 0.01). (C) Disease activity index, a composite 
measure of weight loss, stool consistency and blood in stool (n=7 per time point, *p < 
0.05, **P < 0.01). (D) Left panel: representative images of Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl mice colon on day 28. Right panel: Average of colon length with SEM at 




Figure 12. EP4 depletion of macrophages had no influence on the cellular proportion 
in lamina propria during colitis 
Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in drinking 
water for 5 days. Mice were exposed to tamoxifen diet throughout experiment. (A) MPO 
activity was measured in the colon lysate of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice at 
indicated time points. (B-D) The number of total leucocytes (B), neutrophils (C) and 
monocytes (D) from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice colon were analyzed (n=2-4 





Figure 13. Deletion of EP4 in macrophages shows loss of mucosal regeneration 
Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in drinking 
water for 5 days. Mice were exposed to tamoxifen diet throughout experiment. (A) 
Representative images of hematoxylin and eosin staining of colon tissue from Ptger4fl/fl 
and Csf1r-cre;Ptger4fl/fl mice at indicated time point. Arrowhead: crypt loss and erosion. 
Scale bars = 100 μm. (B) Histological tissue damage and inflammation scoring at 





Figure 14. EP4 expressing macrophage is a major cellular source driving intestinal 
regeneration 
(A) Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in drinking water for 5 
days. Mice were exposed to tamoxifen diet throughout experiment. Csf1r-cre;Ptger4fl/fl 
mice were intraperitoneally injected (i.p.) with 2 × 106 macrophages (MPs) or dendritic 
cells (DCs) isolated from Ptger4fl/fl mice, as indicated (n = 3-4 per group). MPs were 
routinely > 95% F4/80+/CD11b+ cells and DCs were routinely > 40% CD11c+ CD11bint 
MHChi cells. (B) Immunofluorescence staining for transferred cells (DiI, red) and nuclei 
(DAPI, blue) in colon tissues. Broken lines indicate the lamina propria boundary. Scale 
bars =100 μm. (C) Representative images of Csf1r-cre;Ptger4fl/fl mice colon on day 30. 





Figure 15. EP4 expressing macrophages induce regenerative responses of the 
damaged intestinal epithelium  
Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in drinking 
water for 5 days. Mice were exposed to tamoxifen diet throughout experiment. (A) The 
number of crypts in 500 μm length of colon were measured using Image (n=7 per time 
point, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). (B) Ki67+ epithelial cell 
isolated from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice on day 28 determined using flow 
cytometry. Gating of CD45-EpCAM+ epithelial cells and quantitative graph for the 
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number of Ki67+ cells are shown in right. (n=15-20 per group, ****P < 0.0001) (C) Left 
panel: Representative images of Ki67 staining in the colon of Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl mice from different times during DSS-induced colitis are shown. Scale bars 
= 100 μm. Right panel: The number of Ki67+ cells/colon crypt was quantified on day 21 






Figure 16. Expression of epithelial proliferation related genes is reduced in 
epithelium from Csf1r-cre;Ptger4fl/fl mice 
(A) Heat maps representing genes (labels to the right of plots) with relative gene 
expression in whole colon epithelium of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice using 
quantitative real-time PCR (qPCR). Warm color (red) denotes an increase of gene 
expression whereas cold color (blue) indicates a decrease compared to average level of 
gene expression in naïve Ptger4fl/fl. Gene expression of Lgr5 (B) and Bmi1 (C) at 





Figure 17. IL-4 is not required for intestinal wound healing   
(A) C57BL/6 mice were orally administered 2.5% DSS in drinking water for 5 days. IL-
4 neutralizing antibody (nIL-4 Ab) or corresponding isotype Abs (25 μg per mouse) were 
injected i.p. three times a week throughout the whole recovery period. Percentage change 
in body weight. (n=3 per time point). (B) Quantitative graph shows the intensities of p-
STAT6 in CD45+CD11b+Ly6G-Ly6C-MHCII+ macrophages from mice colon. (C) 
Representative images of colon of mice treated with nIL-4 Ab or control-IgG on day 25. 
The number of CD206+ (D), Arg1+ and Retnla+ (E) macrophages from colon of nIL-4 Ab 





Figure 18. Macrophage EP4 signaling promotes the wound healing function of 
colonic macrophages 
(A-C) Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice on day 39 after induction with 2.5% DSS 
in the drinking water. Mice were exposed to tamoxifen diet throughout experiment. (A) 
representative images of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice colon. The number of 
CD206+ (B), Arg1+ and Retnla+(C) macrophages (CD45+CD11b+Ly6G-Ly6C-MHCII+) 
from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice colon was analyzed (n=8 per group, **p < 
0.01, ***p < 0.001). (D) The number of CD64+Ly6C-MHCII+ mature macrophages in 
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colon from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice at indicated time points (n=3-4 per 
time points). (E) Correlation plot between relative mean fluorescent intensity (MFI) of 
EP4 and CD206 of CD45+CD11b+Ly6G-Ly6C-MHCII+macrophages from Ptger4fl/fl and 
Csf1r-cre;Ptger4fl/fl mice colon. Quantitative graph for the R square of EP4 and CD206 





Figure 19. RNAseq of colonic macrophages reveals EP4 signaling in macrophages is 
require for wound healing function 
(A-F) Genome-wide transcriptional profiles of colonic macrophages of Ptger4fl/fl and 
Csf1r-cre;Ptger4fl/fl mice from different times during DSS-induced colitis. (A) 
upregulated gene set in Ptger4fl/fl (Category I) and Csf1r-cre;Ptger4fl/fl (Category II). Heat 
maps representing genes (labels to the right of plots) clustered in Gene Ontology 
Biological Process (GOBP) responses to wound healing (B), regulation of multi-organ 
process (C) and immune response (D) (labels to the left of plots) with scaled log2 
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fluorescence intensity. Warm color (red) denotes an increase of gene expression whereas 
cold color (blue) indicates a decrease compared to average level of gene expression in 
naïve macrophages. (E) GO analysis of Ptger4fl/fl up-regulated genes in colonic 





Figure 20. Cxcl1 production is reduced in colon lamina propria mononuclear cells 
(LPMCs) from Csf1r-cre;Ptger4fl/fl mice 
(A) Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice were orally administered 2.5% DSS in 
drinking water for 5 days. Mice were exposed to tamoxifen diet throughout experiment. 
Csf1r-cre;Ptger4fl/fl mice were injected with the supernatant of WT lamina propria 
mononuclear cells (LPMC) total six times. (B) Representative images of Ptger4fl/fl and 
Csf1r-cre;Ptger4fl/fl mice colon with or without LPMC culture supernatant on day 40. 
Right panel: Average of colon length with SEM (n=3-9 per group. *P < 0.05, ***P < 
0.001). (C) Cxcl1 levels in LPMC culture supernatant obtained from Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl mice (n=5-6. **P < 0.01). Relative Cxcl1 gene expression (D) and Cxcl1 
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levels (E) in whole colon of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice (n=5-6. **P < 0.01, 





Figure 21. Expression of Cxcl1 is reduced in colon of Csf1r-cre;Ptger4fl/fl mice 
(A) Confocal images of colon sections of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice stained 
for F4/80 (green), Cxcl1 (Red) and DAPI (blue). Arrows indicate double-positive cells. 






Figure 22. Cxcl1 is necessary for the intestinal epithelial regeneration 
(A) The intestinal crypt organoids were cultured with differentiation medium containing 
recombinant Cxcl1 (10ng/ml). (B) Quantitative statistics of the number of budding crypts 
(D7) after incubation with recombinant Cxcl1 were compiled (n=10-11. ****P < 0.001). 
Scale bar, 100 μm. (C) Confocal images of intestinal crypt organoids stained for E-
Cadherin (green), Ki67 (Red) and DAPI (blue). Scale bar, 100 μm. Relative Ki67 






Figure 23. Cxcl1 production from EP4+ macrophages promote the intestinal 
epithelial regeneration 
(A) The intestinal crypt organoids were cultured in differentiation medium containing the 
supernatant of LPMCs, which were isolated from colitis Ptger4fl/fl and Csf1r-
cre;Ptger4fl/fl mouse. Cxcl1 neutralizing antibody (nCxcl1 Ab) were added to Ptger4fl/fl 
group. (B) Quantitative statistics of the number of budding crypts (D7) after incubation 
with supernatant of LPMCs (n=5-8. ***P < 0.001). (C) The intestinal crypt organoids 
were cultured in differentiation medium containing the cuture media of BMDMs, which 
were isolated from colitis Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mouse. Cxcl1 neutralizing 
antibody (nCxcl1 Ab) were added to Ptger4fl/fl group. (D) Quantitative statistics of the 
number of budding crypts (D7) after incubation with the cuture media of BMDMs (n=5-




Figure 24. Increased Cxcl1 during the recovery phase is correlated with the 
increased PGE2 
(A) Gene transcripts of Cxcl1 in BMDMs from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice 
determined using qPCR. BMDMs were treated with PGE2 (10 µM) for 48 hours (n=5. *P 
< 0.05). (B) Production of Cxcl1 levels in BMDMs of Ptger4fl/fl, EP2-/- and Csf1r-
cre;Ptger4fl/fl mice after 72 hours of PGE2 treatment. (n=4. **P < 0.01, ***P < 0.001, 
****P < 0.001). Production of PGE2 levels was measured in sera (C) and colon lysate (D) 
of Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl mice at indicated time points. Production of Cxcl1 
levels in sera (E) and colon lysate (F) obtained from Ptger4fl/fl and Csf1r-cre;Ptger4fl/fl 
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mice on day 35 as quantified by ELISA (n=3. *P < 0.05). (G) Colon length and (H) Cxcl1 
levels in colon lysate and of day 21 DSS induced colitis mice received indomethacin in 





Figure 25. Cxcl1 is produced under the PGE2/EP4/MAPKs axis in macrophages 
Cxcl1 production by BMDMs determined by ELISA. (A) BMDMs were treated with 10 
μM PGE2 or 50 μM cAMP activator forskolin for 72 hours after pretreatment with 40 μM 
PKA inhibitor H‐89. BMDMs were pretreated with 1 μM PD98059 (ERK inhibitor), 0.5 
μM SB203580 (p38 inhibitor), or 0.5 μM SP600125 (JNK inhibitor) 1 hour before being 





Figure 26. Schematic summary  
PGE2 potentiates anti-inflammatory phenotype of macrophage through EP4-cAMP-PKA 
cascade. macrophage EP4 signaling promotes the wound healing function of colonic 
macrophages by increasing IL-10, Arginase I and Retnla. Cxcl1 Production by 






In this study, I identified EP4+ macrophages as the major inducer for the epithelial 
regeneration in a damaged intestine. EP4 expression of macrophages did not appear to be 
necessary for normal maintenance of crypts, because Csf1r-cre;Ptger4fl/fl colonic crypts 
had normal morphology. Nonetheless, my data indicated that EP4 expression of 
macrophages orchestrated the proliferation and survival of epithelial progenitors during 
resolving phase. Monocyte derived macrophages obtained wound healing phenotype in a 
EP4 dependent manner and was sufficient to promote expansion of crypt organoids, an 
effect mainly dependent on Cxcl1. PGE2 was increased above the homeostatic level 
during the resolution phase of intestinal inflammation, contributing to the production of 
Cxcl1 from EP4+ macrophages. Recent genome-wide association studies demonstrated a 
significant association of single-nucleotide polymorphisms within the proximity of the 
PTGER4 gene region, which regulate EP4 expression, with Crohn’s disease (21). Apart 
from the previous studies demonstrating the pathogenesis of IBDs regarding PTGER4 
SNPs, such as the EP4-mediated intestinal immune tolerance and maintaining mucosal 
integrity, my study presented here reveals an essential role of EP4 expressing 
macrophages on the mucosal wound healing, supporting a new idea on the treatment of 
such cases of IBDs (21, 22). 
Many other studies indicate the formation, proper functioning, and survival of stem cells 
is strongly influenced by their local microenvironment (23, 24). In the intestine, several 
mesenchymal constituents form structural components of the intestinal stem cell niche 
(25). Subepithelial myofibroblasts migrate upward from the crypt base, placing them in 
strategic position to establish and maintain instructive communications with stem cells 
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and their descendants (26). A submucosal plexus of enteric neurons communicates with 
a subset of crypt epithelial progenitors in a growth factor-signaling pathway dependent 
manner(27). The microvasculature underlying the crypt base also effects stem cell 
survival. CD34+ mesenchymal cells are a component of the intestinal stem cell niche after 
injury by producing Wnt2b, Grmlin1 and R-spondin1 (28). Activated macrophages also 
has been revealed as one of critical elements of the colonic epithelial stem cell niche 
necessary for regenerative responses to injury (29). Since this important study has been 
reported in 2005, several supporting mechanisms have been published so far. Wnt ligands 
are the most frequently mentioned effectors from macrophages, for example, macrophage 
derived extracellular vesicle-packaged Wnts rescue intestinal stem cells in radiation 
injury model (30). In addition, IL-4/STAT6-dependent Wnt productions from 
macrophages were critical in mucosal repair in 2,4,6-trinitrobenzene sulfonic acid (TNBS) 
induced colitis model (31). By contrast, I could not find significant difference of Wnt 
transcripts including Wnt2b, Wnt6, Wnt7b and Wnt10a between the intestinal Ptger4fl/fl 
macrophages and Csf1r-cre;Ptger4fl/fl macrophages from my RNA sequencing data (data 
not shown). Quiros et al. showed that macrophage derived IL-10 induced epithelial CREB 
activation and subsequence synthesis of the pro-repair WNT1-inducible signaling 
proteins 1 (WISP-1) followed by mucosal healing in punch biopsy model (32), however, 
IL-10 expression of macrophages was not significant different in WT and EP4-/- mice in 
this study. In addition, I could not observe a role of IL-4 in inducing CD206+ macrophages 
in my colitis model, whereas Bosurgi et al. showed the increased CD206 expression by 
stimulation with concomitant IL-4 and apoptotic cells in DSS induced colitis model (33). 
One of the difference between these studies and my work is that I focused to investigate 
the phenotype of macrophages in the late recovery phase, whereas most of other studies 
performed their experiments at the inflammatory phase. None of other studies showed the 
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complete defect of wound healing in intestinal inflammation model distinct in contrast 
with my results, thus I am strongly convinced that PGE2/EP4 axis in macrophages is a 
critical component of mucosal healing machinery.  
  
PGE2 is an eicosanoid that modulates diverse physiologic and pathologic functions. To 
avoid undesired effects associated with dysregulated inflammation, PGE2 tissue 
concentrations are tightly regulated by expression of COX1 and COX2, mPGES1 
biosynthetic enzymes, as well as degradative enzymes (15-PGDH). The COX1 and 
COX2 enzymes are responsible for the catabolism of arachidonic acid into PGH2, the 
precursor of PGI2, PGD2, PGF2a, TxA2 and PGE2 (34). In a homeostatic state, intestine 
has the highest contents of PGE2 among known other tissues such as lung, bone marrow 
and liver. COX2 and mPGES1 expressions mostly localize in the lamina propria, 
specifically abundant in monocyte/macrophages (35). During inflammation, contradicted 
data has been reported about the tissue level of PGE2. Peng et al. showed that COX-1 and 
PGE2 were significantly decreased in colon of UC patients and mice of DSS model (36), 
by contrast, Maseda et al. showed increased PGE2 in colon from T-cell transfer mediated 
colitis model (35). Although with different model, Ho et al. also showed a surge of PGE2 
in damaged muscle tissue (8). In this study, I observed a slight decrease during 
inflammatory phase and a clearly increased PGE2 both in colon and blood at the late 
resolving phase in my DSS-induced colitis model (Figure 25C-D). This means that a 
complete resolution to the homeostasis takes a time much more than I expected, and the 
reconstructed tissue components might increase PGE2 production via high expressions of 




The presence of CD206+ regulatory macrophages were recently suggested as a prognostic 
factor in determining response rate to the anti-TNFα therapy in CD patients (37). 
Ipilimumab Fc portion mediated Fcγ receptor activation and the classical alternative 
activator IL-4 are known factors inducing CD206+ macrophages (37), however, the 
reasons for how they are created in intestine is still not sufficiently understood. The strict 
correlation between EP4 and CD206 expression shown in this study thus identify a new 
mechanistic role of EP4 for inducing and maintaining CD206+ macrophages which played 
a critical function in intestinal wound healing. EP4 expression on macrophages continued 
to increase during inflammation and peak at the resolution phase, rendering the full 
responsiveness to the increased PGE2 which directly aided wound healing phenotype of 
macrophages via EP4 signaling pathway. 
Several lines of evidence from clinical and animal model studies have shown that Cxcl1 
plays a beneficial role by trafficking and activating neutrophils in response to infections 
(38-40). Cxcl1 produced by resident macrophages and/or epithelial cells rapidly travels 
to the bloodstream, where it orchestrates neutrophil trafficking from vasculature into the 
tissue (41, 42). Although Cxcl1 may be dangerous for treatment of colitis because of 
neutrophil trafficking, from my data that level of Cxcl1in colon or blood of Csf1r-
cre;Ptger4fl/fl mice at 39 dpt was lower than that of naïve mice, I could predict that 
appropriate level of Cxcl1 needs to tissue regeneration during the resolution phase.  
Wang et al. identified mechanism that PGE2 stimulates expression of the CXCL1 in 
colorectal cancer cells through activation of an the EGFR–MAPK cascade (43). I also 
observed similar mechanism that PGE2/EP4/MAPK signaling axis involved in Cxcl1 
production of macrophages. However, roles of Cxcl1 in the regulation of intestinal 
epithelial remains largely undefined. In this study, for the first time, I showed that Cxcl1 
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production from EP4+ macrophages was necessary for the intestinal epithelial 
regeneration (Figure 24).  
The treatment of EP4 agonist has shown to provide a beneficial effect in mice models of 
colitis (44) and in a Phase II trial with ulcerative colitis patients (45). Although the 
beneficial effects of EP4 agonists are likely mediated through multiple EP4-expressing 
cell types, my data suggests that EP4 expressing macrophages have a benefit on improved 
wound repair response of the intestinal epithelium. For future macrophage EP4 signaling-
directed IBD therapeutics, one of the target drugs is MAPKs activator asiatic acid that 
result in increased Cxcl1 production of macrophages. It has been reported that asiatic acid 
ameliorated DSS-induced murine experimental colitis through inhibition of NLRP3 
inflammasome activation (46). Targeted drug delivery to macrophages is therefore one of 
the remaining challenges to obtaining high drug efficacy without substantial adverse 
effects. For example, macrophage-targeting nanoparticles, such as mannosylated or folic 
acid conjugated liposomes, could be synthesized to deliver specific pathway inhibitors or 
agonists to promote differentiation of CD206+ or folate receptor-positive (FR+) 
inflammatory myeloid cells into resolution macrophages in the colon (47). 
In conclusion, the present study has revealed that the expression of EP4 on macrophages 
helps to maintain colonic epithelial barrier integrity, and recovers damaged mucosal by 
Cxcl1 up-regulation of PGE2/EP4/MAPK signaling. These results suggest that EP4 
signaling of macrophages has a favorable therapeutic effect on DSS-induced ulcerative 
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장 조직이 손상되었을 때 장 상피세포 장벽의 회복은 장관내 미생물 균총을 
격리하여 만성적인 염증이 일어나는 것을 막아준다. 따라서 장 조직의 
재생이 제대로 일어나지 않으면 장관내 미생물에 대한 면역반응이 
지속적으로 일어나 염증성 대장염을 야기하게 되며 질환으로부터의 완전한 
회복을 위해서는 손상된 장 조직이 적절한 재생을 거쳐 해부학적 장벽을 
형성해야 한다. 큰포식세포는 상처 치유의 기본적인 요소 중에 하나로 잘 
알려져 있으나 장에 있는 큰포식세포의 조직 재생 능력에 기여하는 주요한 
요소가 무엇인지에 대해서는 잘 알려져 있지 않다. 본 연구에서는 
큰포식세포에서 지질매개인자인 PGE2 의 수용체 중 하나인 EP4 수용체의 
발현이 손상 받은 장 조직 재생에 핵심적으로 관여하는 것을 증명하였다. 
먼저 큰포식세포 특이적으로 EP4 를 발현하지 않는 마우스 (Csf1r-
Cre/Esr1EP4fl/fl)를 제작하여 대장염을 일으킨 후 장염의 회복기에 여전히 
짧은 장 길이 및 높은 질병 활성도 등을 확인하여 장염의 회복이 잘 
일어나지 않음을 확인하였다. 또한 EP4 를 발현하는 큰포식세포는 
CD206를 높게 발현하고 있었으며 세포 내 cAMP 를 많이 발현하고 있었다. 
이는 EP4 가 상처치유 큰포식세포 형성에 중요한 기능을 하고 있음을 
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암시하고 있다. 더 나아가 회복기 시기의 큰포식세포에 대한 대단위 유전체 
분석을 통하여 EP4 신호전달 체계에 의한 큰포식세포의 조직재생능력 
향상과 연관 있는 분자생물학적 기전을 확립하고자 하였다. 대단위 유전체 
분석을 통하여 Cxcl1 의 발현이 Csflr-EP4-/- 마우스 유래 장 
큰포식세포에서 크게 감소하는 것을 확인하였으며, Cxcl1 이 
PGE2/EP4/MAPK 신호전달 체계를 통해서 crypt 의 분열을 도와 장 
상피세포 분열을 촉진시킬 수 있음을 확인하였다. 본 연구결과로 염증성 
대장염 모델의 조직 수복 시기에 조직의 적절한 재생이 이루어지기 위하여 
EP4 에 의한 큰포식세포의 PGE2/EP4/MAPK 신호전달체계 활성이 
필요함을 확인하고 장 손상에 대한 재생 유도 반응의 전체적인 세포간 
네트워크에서 큰포식세포가 Cxcl1 생산을 통하여 관여하는 분자생물학적 
기전을 새롭게 밝혔다. 
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